IPSEYOTCHealthcare · Drug Manufacturers - Specialty & Generic

Ipsen S.A.

$48.76+0.00%(+$0.00)

TickerSpark Score

84/100

Strong

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IPSEY research report →

52-Week Range90% of range

Low $28.59

Current $48.76

High $51.10

Companywww.ipsen.com

Ipsen S. A. operates as a biopharmaceutical company worldwide.

CEO: David Loew
IPO: 2012
Employees: 5,358
HQ: Boulogne-Billancourt, FR

Price Chart

+66.19% · this period

Valuation

Market Cap: $64.48B
P/E: 29.58
P/S: 3.59
P/B: 3.03
EV/EBITDA: 11.54
Div Yield: 0.88%

Profitability

Gross Margin: 70.58%
Op Margin: 30.70%
Net Margin: 12.07%
ROE: 10.36%
ROIC: 15.40%

Growth & Income

Revenue: $3.53B · -1.22%
Net Income: $426.96M · 23.43%
EPS: $1.28 · 22.25%
Op Income: $716.85M
FCF YoY: 646.11%

Performance & Tape

52W High: $51.10
52W Low: $28.59
50D MA: $47.47
200D MA: $39.44
Beta: 0.33
Avg Volume: 661

Get TickerSpark's AI analysis on IPSEY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime